{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T19:06:47Z","timestamp":1776107207353,"version":"3.50.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"7785","license":[{"start":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T00:00:00Z","timestamp":1574208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T00:00:00Z","timestamp":1574208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2019,12,5]]},"DOI":"10.1038\/s41586-019-1775-1","type":"journal-article","created":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T14:02:47Z","timestamp":1574258567000},"page":"112-120","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":478,"title":["Longitudinal molecular trajectories of diffuse glioma in adults"],"prefix":"10.1038","volume":"576","author":[{"given":"Floris P.","family":"Barthel","sequence":"first","affiliation":[]},{"given":"Kevin C.","family":"Johnson","sequence":"additional","affiliation":[]},{"given":"Frederick S.","family":"Varn","sequence":"additional","affiliation":[]},{"given":"Anzhela D.","family":"Moskalik","sequence":"additional","affiliation":[]},{"given":"Georgette","family":"Tanner","sequence":"additional","affiliation":[]},{"given":"Emre","family":"Kocakavuk","sequence":"additional","affiliation":[]},{"given":"Kevin J.","family":"Anderson","sequence":"additional","affiliation":[]},{"given":"Olajide","family":"Abiola","sequence":"additional","affiliation":[]},{"given":"Kenneth","family":"Aldape","sequence":"additional","affiliation":[]},{"given":"Kristin D.","family":"Alfaro","sequence":"additional","affiliation":[]},{"given":"Donat","family":"Alpar","sequence":"additional","affiliation":[]},{"given":"Samirkumar B.","family":"Amin","sequence":"additional","affiliation":[]},{"given":"David M.","family":"Ashley","sequence":"additional","affiliation":[]},{"given":"Pratiti","family":"Bandopadhayay","sequence":"additional","affiliation":[]},{"given":"Jill S.","family":"Barnholtz-Sloan","sequence":"additional","affiliation":[]},{"given":"Rameen","family":"Beroukhim","sequence":"additional","affiliation":[]},{"given":"Christoph","family":"Bock","sequence":"additional","affiliation":[]},{"given":"Priscilla K.","family":"Brastianos","sequence":"additional","affiliation":[]},{"given":"Daniel J.","family":"Brat","sequence":"additional","affiliation":[]},{"given":"Andrew R.","family":"Brodbelt","sequence":"additional","affiliation":[]},{"given":"Alexander F.","family":"Bruns","sequence":"additional","affiliation":[]},{"given":"Ketan R.","family":"Bulsara","sequence":"additional","affiliation":[]},{"given":"Aruna","family":"Chakrabarty","sequence":"additional","affiliation":[]},{"given":"Arnab","family":"Chakravarti","sequence":"additional","affiliation":[]},{"given":"Jeffrey H.","family":"Chuang","sequence":"additional","affiliation":[]},{"given":"Elizabeth B.","family":"Claus","sequence":"additional","affiliation":[]},{"given":"Elizabeth J.","family":"Cochran","sequence":"additional","affiliation":[]},{"given":"Jennifer","family":"Connelly","sequence":"additional","affiliation":[]},{"given":"Joseph F.","family":"Costello","sequence":"additional","affiliation":[]},{"given":"Gaetano","family":"Finocchiaro","sequence":"additional","affiliation":[]},{"given":"Michael N.","family":"Fletcher","sequence":"additional","affiliation":[]},{"given":"Pim J.","family":"French","sequence":"additional","affiliation":[]},{"given":"Hui K.","family":"Gan","sequence":"additional","affiliation":[]},{"given":"Mark R.","family":"Gilbert","sequence":"additional","affiliation":[]},{"given":"Peter V.","family":"Gould","sequence":"additional","affiliation":[]},{"given":"Matthew R.","family":"Grimmer","sequence":"additional","affiliation":[]},{"given":"Antonio","family":"Iavarone","sequence":"additional","affiliation":[]},{"given":"Azzam","family":"Ismail","sequence":"additional","affiliation":[]},{"given":"Michael D.","family":"Jenkinson","sequence":"additional","affiliation":[]},{"given":"Mustafa","family":"Khasraw","sequence":"additional","affiliation":[]},{"given":"Hoon","family":"Kim","sequence":"additional","affiliation":[]},{"given":"Mathilde C. M.","family":"Kouwenhoven","sequence":"additional","affiliation":[]},{"given":"Peter S.","family":"LaViolette","sequence":"additional","affiliation":[]},{"given":"Meihong","family":"Li","sequence":"additional","affiliation":[]},{"given":"Peter","family":"Lichter","sequence":"additional","affiliation":[]},{"given":"Keith L.","family":"Ligon","sequence":"additional","affiliation":[]},{"given":"Allison K.","family":"Lowman","sequence":"additional","affiliation":[]},{"given":"Tathiane M.","family":"Malta","sequence":"additional","affiliation":[]},{"given":"Tali","family":"Mazor","sequence":"additional","affiliation":[]},{"given":"Kerrie L.","family":"McDonald","sequence":"additional","affiliation":[]},{"given":"Annette M.","family":"Molinaro","sequence":"additional","affiliation":[]},{"given":"Do-Hyun","family":"Nam","sequence":"additional","affiliation":[]},{"given":"Naema","family":"Nayyar","sequence":"additional","affiliation":[]},{"given":"Ho Keung","family":"Ng","sequence":"additional","affiliation":[]},{"given":"Chew Yee","family":"Ngan","sequence":"additional","affiliation":[]},{"given":"Simone P.","family":"Niclou","sequence":"additional","affiliation":[]},{"given":"Johanna M.","family":"Niers","sequence":"additional","affiliation":[]},{"given":"Houtan","family":"Noushmehr","sequence":"additional","affiliation":[]},{"given":"Javad","family":"Noorbakhsh","sequence":"additional","affiliation":[]},{"given":"D. Ryan","family":"Ormond","sequence":"additional","affiliation":[]},{"given":"Chul-Kee","family":"Park","sequence":"additional","affiliation":[]},{"given":"Laila M.","family":"Poisson","sequence":"additional","affiliation":[]},{"given":"Raul","family":"Rabadan","sequence":"additional","affiliation":[]},{"given":"Bernhard","family":"Radlwimmer","sequence":"additional","affiliation":[]},{"given":"Ganesh","family":"Rao","sequence":"additional","affiliation":[]},{"given":"Guido","family":"Reifenberger","sequence":"additional","affiliation":[]},{"given":"Jason K.","family":"Sa","sequence":"additional","affiliation":[]},{"given":"Michael","family":"Schuster","sequence":"additional","affiliation":[]},{"given":"Brian L.","family":"Shaw","sequence":"additional","affiliation":[]},{"given":"Susan C.","family":"Short","sequence":"additional","affiliation":[]},{"given":"Peter A. Sillevis","family":"Smitt","sequence":"additional","affiliation":[]},{"given":"Andrew E.","family":"Sloan","sequence":"additional","affiliation":[]},{"given":"Marion","family":"Smits","sequence":"additional","affiliation":[]},{"given":"Hiromichi","family":"Suzuki","sequence":"additional","affiliation":[]},{"given":"Ghazaleh","family":"Tabatabai","sequence":"additional","affiliation":[]},{"given":"Erwin G.","family":"Van Meir","sequence":"additional","affiliation":[]},{"given":"Colin","family":"Watts","sequence":"additional","affiliation":[]},{"given":"Michael","family":"Weller","sequence":"additional","affiliation":[]},{"given":"Pieter","family":"Wesseling","sequence":"additional","affiliation":[]},{"given":"Bart A.","family":"Westerman","sequence":"additional","affiliation":[]},{"given":"Georg","family":"Widhalm","sequence":"additional","affiliation":[]},{"given":"Adelheid","family":"Woehrer","sequence":"additional","affiliation":[]},{"given":"W. K. Alfred","family":"Yung","sequence":"additional","affiliation":[]},{"given":"Gelareh","family":"Zadeh","sequence":"additional","affiliation":[]},{"given":"Jason T.","family":"Huse","sequence":"additional","affiliation":[]},{"given":"John F.","family":"De Groot","sequence":"additional","affiliation":[]},{"given":"Lucy F.","family":"Stead","sequence":"additional","affiliation":[]},{"given":"Roel G. W.","family":"Verhaak","sequence":"additional","affiliation":[]},{"name":"The GLASS Consortium","sequence":"additional","affiliation":[]},{"given":"Floris P.","family":"Barthel","sequence":"additional","affiliation":[]},{"given":"Kevin C.","family":"Johnson","sequence":"additional","affiliation":[]},{"given":"Frederick S.","family":"Varn","sequence":"additional","affiliation":[]},{"given":"Anzhela D.","family":"Moskalik","sequence":"additional","affiliation":[]},{"given":"Georgette","family":"Tanner","sequence":"additional","affiliation":[]},{"given":"Emre","family":"Kocakavuk","sequence":"additional","affiliation":[]},{"given":"Kevin J.","family":"Anderson","sequence":"additional","affiliation":[]},{"given":"Kenneth","family":"Aldape","sequence":"additional","affiliation":[]},{"given":"Kristin D.","family":"Alfaro","sequence":"additional","affiliation":[]},{"given":"Samirkumar B.","family":"Amin","sequence":"additional","affiliation":[]},{"given":"David M.","family":"Ashley","sequence":"additional","affiliation":[]},{"given":"Pratiti","family":"Bandopadhayay","sequence":"additional","affiliation":[]},{"given":"Jill S.","family":"Barnholtz-Sloan","sequence":"additional","affiliation":[]},{"given":"Rameen","family":"Beroukhim","sequence":"additional","affiliation":[]},{"given":"Christoph","family":"Bock","sequence":"additional","affiliation":[]},{"given":"Priscilla K.","family":"Brastianos","sequence":"additional","affiliation":[]},{"given":"Daniel J.","family":"Brat","sequence":"additional","affiliation":[]},{"given":"Andrew R.","family":"Brodbelt","sequence":"additional","affiliation":[]},{"given":"Ketan R.","family":"Bulsara","sequence":"additional","affiliation":[]},{"given":"Aruna","family":"Chakrabarty","sequence":"additional","affiliation":[]},{"given":"Jeffrey H.","family":"Chuang","sequence":"additional","affiliation":[]},{"given":"Elizabeth B.","family":"Claus","sequence":"additional","affiliation":[]},{"given":"Elizabeth J.","family":"Cochran","sequence":"additional","affiliation":[]},{"given":"Jennifer","family":"Connelly","sequence":"additional","affiliation":[]},{"given":"Joseph F.","family":"Costello","sequence":"additional","affiliation":[]},{"given":"Gaetano","family":"Finocchiaro","sequence":"additional","affiliation":[]},{"given":"Michael N.","family":"Fletcher","sequence":"additional","affiliation":[]},{"given":"Pim J.","family":"French","sequence":"additional","affiliation":[]},{"given":"Hui K.","family":"Gan","sequence":"additional","affiliation":[]},{"given":"Mark R.","family":"Gilbert","sequence":"additional","affiliation":[]},{"given":"Peter V.","family":"Gould","sequence":"additional","affiliation":[]},{"given":"Antonio","family":"Iavarone","sequence":"additional","affiliation":[]},{"given":"Azzam","family":"Ismail","sequence":"additional","affiliation":[]},{"given":"Michael D.","family":"Jenkinson","sequence":"additional","affiliation":[]},{"given":"Mustafa","family":"Khasraw","sequence":"additional","affiliation":[]},{"given":"Hoon","family":"Kim","sequence":"additional","affiliation":[]},{"given":"Mathilde C. M.","family":"Kouwenhoven","sequence":"additional","affiliation":[]},{"given":"Peter S.","family":"LaViolette","sequence":"additional","affiliation":[]},{"given":"Peter","family":"Lichter","sequence":"additional","affiliation":[]},{"given":"Keith L.","family":"Ligon","sequence":"additional","affiliation":[]},{"given":"Allison K.","family":"Lowman","sequence":"additional","affiliation":[]},{"given":"Tathiane M.","family":"Malta","sequence":"additional","affiliation":[]},{"given":"Kerrie L.","family":"McDonald","sequence":"additional","affiliation":[]},{"given":"Annette M.","family":"Molinaro","sequence":"additional","affiliation":[]},{"given":"Do-Hyun","family":"Nam","sequence":"additional","affiliation":[]},{"given":"Ho Keung","family":"Ng","sequence":"additional","affiliation":[]},{"given":"Simone P.","family":"Niclou","sequence":"additional","affiliation":[]},{"given":"Johanna M.","family":"Niers","sequence":"additional","affiliation":[]},{"given":"Houtan","family":"Noushmehr","sequence":"additional","affiliation":[]},{"given":"D. Ryan","family":"Ormond","sequence":"additional","affiliation":[]},{"given":"Chul-Kee","family":"Park","sequence":"additional","affiliation":[]},{"given":"Laila M.","family":"Poisson","sequence":"additional","affiliation":[]},{"given":"Raul","family":"Rabadan","sequence":"additional","affiliation":[]},{"given":"Bernhard","family":"Radlwimmer","sequence":"additional","affiliation":[]},{"given":"Ganesh","family":"Rao","sequence":"additional","affiliation":[]},{"given":"Guido","family":"Reifenberger","sequence":"additional","affiliation":[]},{"given":"Jason K.","family":"Sa","sequence":"additional","affiliation":[]},{"given":"Susan C.","family":"Short","sequence":"additional","affiliation":[]},{"given":"Peter A. Sillevis","family":"Smitt","sequence":"additional","affiliation":[]},{"given":"Andrew E.","family":"Sloan","sequence":"additional","affiliation":[]},{"given":"Marion","family":"Smits","sequence":"additional","affiliation":[]},{"given":"Hiromichi","family":"Suzuki","sequence":"additional","affiliation":[]},{"given":"Ghazaleh","family":"Tabatabai","sequence":"additional","affiliation":[]},{"given":"Erwin G.","family":"Van Meir","sequence":"additional","affiliation":[]},{"given":"Colin","family":"Watts","sequence":"additional","affiliation":[]},{"given":"Michael","family":"Weller","sequence":"additional","affiliation":[]},{"given":"Pieter","family":"Wesseling","sequence":"additional","affiliation":[]},{"given":"Bart A.","family":"Westerman","sequence":"additional","affiliation":[]},{"given":"Adelheid","family":"Woehrer","sequence":"additional","affiliation":[]},{"given":"W. K. Alfred","family":"Yung","sequence":"additional","affiliation":[]},{"given":"Gelareh","family":"Zadeh","sequence":"additional","affiliation":[]},{"given":"Jason T.","family":"Huse","sequence":"additional","affiliation":[]},{"given":"John F.","family":"De\u00a0Groot","sequence":"additional","affiliation":[]},{"given":"Lucy F.","family":"Stead","sequence":"additional","affiliation":[]},{"given":"Roel G. W.","family":"Verhaak","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2019,11,20]]},"reference":[{"key":"1775_CR1","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s00401-018-1842-y","volume":"135","author":"FP Barthel","year":"2018","unstructured":"Barthel, F. P., Wesseling, P. & Verhaak, R. G. W. Reconstructing the molecular life history of gliomas. Acta Neuropathol. 135, 649\u2013670 (2018).","journal-title":"Acta Neuropathol."},{"key":"1775_CR2","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nrc3655","volume":"14","author":"D Sturm","year":"2014","unstructured":"Osuka, S. & Van Meir, E. G. Overcoming therapeutic resistance in glioblastoma: the way forward. J. Clin. Invest. 127, 415\u2013426 (2017).","journal-title":"Nat. Rev. Cancer."},{"key":"1775_CR3","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1126\/science.1210557","volume":"333","author":"C Bettegowda","year":"2011","unstructured":"Bettegowda, C. et al. Mutations in CIC and FUBP1 contribute to human oligodendroglioma. Science 333, 1453\u20131455 (2011).","journal-title":"Science"},{"key":"1775_CR4","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1101\/gad.213686.113","volume":"27","author":"S Zheng","year":"2013","unstructured":"Zheng, S. et al. A survey of intragenic breakpoints in glioblastoma identifies a distinct subset associated with poor survival. Genes Dev. 27, 1462\u20131472 (2013).","journal-title":"Genes Dev."},{"key":"1775_CR5","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/nature07385","volume":"455","author":"Cancer Genome Atlas Research Network","year":"2008","unstructured":"Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455, 1061\u20131068 (2008).","journal-title":"Nature"},{"key":"1775_CR6","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.cell.2015.12.028","volume":"164","author":"M Ceccarelli","year":"2016","unstructured":"Ceccarelli, M. et al. Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma. Cell 164, 550\u2013563 (2016).","journal-title":"Cell"},{"key":"1775_CR7","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1056\/NEJMoa1402121","volume":"372","author":"The Cancer Genome Atlas Research Network","year":"2015","unstructured":"The Cancer Genome Atlas Research Network. Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N. Engl. J. Med. 372, 2481\u20132498 (2015).","journal-title":"N. Engl. J. Med."},{"key":"1775_CR8","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","volume":"17","author":"RG Verhaak","year":"2010","unstructured":"Verhaak, R. G. et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17, 98\u2013110 (2010).","journal-title":"Cancer Cell"},{"key":"1775_CR9","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1056\/NEJMoa0808710","volume":"360","author":"H Yan","year":"2009","unstructured":"Yan, H. et al. IDH1 and IDH2 mutations in gliomas. N. Engl. J. Med. 360, 765\u2013773 (2009).","journal-title":"N. Engl. J. Med."},{"key":"1775_CR10","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/bpa.12171","volume":"24","author":"DN Louis","year":"2014","unstructured":"Louis, D. N. et al. International Society of Neuropathology\u2014Haarlem consensus guidelines for nervous system tumor classification and grading. Brain Pathol. 24, 429\u2013435 (2014).","journal-title":"Brain Pathol."},{"key":"1775_CR11","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis, D. N. et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol. 131, 803\u2013820 (2016).","journal-title":"Acta Neuropathol."},{"key":"1775_CR12","doi-asserted-by":"publisher","first-page":"eaai8478","DOI":"10.1126\/science.aai8478","volume":"355","author":"AS Venteicher","year":"2017","unstructured":"Venteicher, A. S. et al. Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq. Science 355, eaai8478 (2017).","journal-title":"Science"},{"key":"1775_CR13","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1126\/science.1254257","volume":"344","author":"AP Patel","year":"2014","unstructured":"Patel, A. P. et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science 344, 1396\u20131401 (2014).","journal-title":"Science"},{"key":"1775_CR14","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.ccr.2011.11.005","volume":"20","author":"M Snuderl","year":"2011","unstructured":"Snuderl, M. et al. Mosaic amplification of multiple receptor tyrosine kinase genes in glioblastoma. Cancer Cell 20, 810\u2013817 (2011).","journal-title":"Cancer Cell"},{"key":"1775_CR15","doi-asserted-by":"publisher","first-page":"4009","DOI":"10.1073\/pnas.1219747110","volume":"110","author":"A Sottoriva","year":"2013","unstructured":"Sottoriva, A. et al. Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. Proc. Natl Acad. Sci. USA 110, 4009\u20134014 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1775_CR16","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/s41588-018-0128-6","volume":"50","author":"MJ Williams","year":"2018","unstructured":"Williams, M. J. et al. Quantification of subclonal selection in cancer from bulk sequencing data. Nat. Genet. 50, 895\u2013903 (2018).","journal-title":"Nat. Genet."},{"key":"1775_CR17","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1158\/2326-6066.CIR-18-0599","volume":"7","author":"T Nejo","year":"2019","unstructured":"Nejo, T. et al. reduced neoantigen expression revealed by longitudinal multiomics as a possible immune evasion mechanism in glioma. Cancer Immunol. Res. 7, 1148\u20131161 (2019).","journal-title":"Cancer Immunol. Res."},{"key":"1775_CR18","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1093\/neuonc\/noy020","volume":"20","author":"The GLASS Consortium","year":"2018","unstructured":"The GLASS Consortium. Glioma through the looking GLASS: molecular evolution of diffuse gliomas and the Glioma Longitudinal Analysis Consortium. Neuro-oncol. 20, 873\u2013884 (2018).","journal-title":"Neuro-oncol."},{"key":"1775_CR19","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/j.cell.2018.09.038","volume":"175","author":"H Hu","year":"2018","unstructured":"Hu, H. et al. Mutational landscape of secondary glioblastoma guides met-targeted trial in brain tumor. Cell 175, 1665\u20131678.e1618 (2018).","journal-title":"Cell"},{"key":"1775_CR20","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature12477","volume":"500","author":"LB Alexandrov","year":"2013","unstructured":"Alexandrov, L. B. et al. Signatures of mutational processes in human cancer. Nature 500, 415\u2013421 (2013).","journal-title":"Nature"},{"key":"1775_CR21","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/ng.3590","volume":"48","author":"J Wang","year":"2016","unstructured":"Wang, J. et al. Clonal evolution of glioblastoma under therapy. Nat. Genet. 48, 768\u2013776 (2016).","journal-title":"Nat. Genet."},{"key":"1775_CR22","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1101\/gr.180612.114","volume":"25","author":"H Kim","year":"2015","unstructured":"Kim, H. et al. Whole-genome and multisector exome sequencing of primary and post-treatment glioblastoma reveals patterns of tumor evolution. Genome Res. 25, 316\u2013327 (2015).","journal-title":"Genome Res."},{"key":"1775_CR23","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1126\/science.1239947","volume":"343","author":"BE Johnson","year":"2014","unstructured":"Johnson, B. E. et al. Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma. Science 343, 189\u2013193 (2014).","journal-title":"Science"},{"key":"1775_CR24","doi-asserted-by":"publisher","first-page":"3987","DOI":"10.1158\/0008-5472.CAN-06-0127","volume":"66","author":"C Hunter","year":"2006","unstructured":"Hunter, C. et al. A hypermutation phenotype and somatic MSH6 mutations in recurrent human malignant gliomas after alkylator chemotherapy. Cancer Res. 66, 3987\u20133991 (2006).","journal-title":"Cancer Res."},{"key":"1775_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-018-1476-3","volume":"19","author":"C Jolly","year":"2018","unstructured":"Jolly, C. & Van Loo, P. Timing somatic events in the evolution of cancer. Genome Biol. 19, 95 (2018).","journal-title":"Genome Biol."},{"key":"1775_CR26","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41576-019-0114-6","volume":"20","author":"S Turajlic","year":"2019","unstructured":"Turajlic, S., Sottoriva, A., Graham, T. & Swanton, C. Resolving genetic heterogeneity in cancer. Nat. Rev. Genet. 20, 404\u2013416 (2019).","journal-title":"Nat. Rev. Genet."},{"key":"1775_CR27","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1093\/neuonc\/noy016","volume":"20","author":"S Choi","year":"2018","unstructured":"Choi, S. et al. Temozolomide-associated hypermutation in gliomas. Neuro-oncol. 20, 1300\u20131309 (2018).","journal-title":"Neuro-oncol."},{"key":"1775_CR28","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1016\/S1470-2045(16)30313-8","volume":"17","author":"BG Baumert","year":"2016","unstructured":"Baumert, B. G. et al. Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study. Lancet Oncol. 17, 1521\u20131532 (2016).","journal-title":"Lancet Oncol."},{"key":"1775_CR29","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1056\/NEJMoa1500925","volume":"374","author":"JC Buckner","year":"2016","unstructured":"Buckner, J. C. et al. Radiation plus procarbazine, CCNU, and vincristine in low-grade glioma. N. Engl. J. Med. 374, 1344\u20131355 (2016).","journal-title":"N. Engl. J. Med."},{"key":"1775_CR30","doi-asserted-by":"publisher","first-page":"127ps10","DOI":"10.1126\/scitranslmed.3003854","volume":"4","author":"TA Yap","year":"2012","unstructured":"Yap, T. A., Gerlinger, M., Futreal, P. A., Pusztai, L. & Swanton, C. Intratumor heterogeneity: seeing the wood for the trees. Sci. Transl. Med. 4, 127ps10 (2012).","journal-title":"Sci. Transl. Med."},{"key":"1775_CR31","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.cell.2017.09.042","volume":"171","author":"I Martincorena","year":"2017","unstructured":"Martincorena, I. et al. Universal patterns of selection in cancer and somatic tissues. Cell 171, 1029\u20131041.e1021 (2017).","journal-title":"Cell"},{"key":"1775_CR32","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/ng.3489","volume":"48","author":"MJ Williams","year":"2016","unstructured":"Williams, M. J., Werner, B., Barnes, C. P., Graham, T. A. & Sottoriva, A. Identification of neutral tumor evolution across cancer types. Nat. Genet. 48, 238\u2013244 (2016).","journal-title":"Nat. Genet."},{"key":"1775_CR33","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.ccell.2019.02.007","volume":"35","author":"V Korber","year":"2019","unstructured":"Korber, V. et al. Evolutionary trajectories of IDH(WT) glioblastomas reveal a common path of early tumorigenesis instigated years ahead of initial diagnosis. Cancer Cell 35, 692\u2013704.e612 (2019).","journal-title":"Cancer Cell"},{"key":"1775_CR34","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/s41588-018-0105-0","volume":"50","author":"AC deCarvalho","year":"2018","unstructured":"deCarvalho, A. C. et al. Discordant inheritance of chromosomal and extrachromosomal DNA elements contributes to dynamic disease evolution in glioblastoma. Nat. Genet. 50, 708\u2013717 (2018).","journal-title":"Nat. Genet."},{"key":"1775_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s13008-015-0009-7","volume":"10","author":"M Giam","year":"2015","unstructured":"Giam, M. & Rancati, G. Aneuploidy and chromosomal instability in cancer: a jackpot to chaos. Cell Div. 10, 3 (2015).","journal-title":"Cell Div."},{"key":"1775_CR36","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.cell.2018.08.048","volume":"175","author":"R Marty","year":"2018","unstructured":"Marty, R., Thompson, W. K., Salem, R. M., Zanetti, M. & Carter, H. Evolutionary pressure against MHC class II binding cancer mutations. Cell 175, 416\u2013428.e413 (2018).","journal-title":"Cell"},{"key":"1775_CR37","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/j.cell.2017.10.001","volume":"171","author":"N McGranahan","year":"2017","unstructured":"McGranahan, N. et al. Allele-specific HLA Loss and immune escape in lung cancer evolution. Cell 171, 1259\u20131271.e1211 (2017).","journal-title":"Cell"},{"key":"1775_CR38","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ccell.2017.06.003","volume":"32","author":"Q Wang","year":"2017","unstructured":"Wang, Q. et al. Tumor evolution of glioma-intrinsic gene expression subtypes associates with immunological changes in the microenvironment. Cancer Cell 32, 42\u201356.e46 (2017).","journal-title":"Cancer Cell"},{"key":"1775_CR39","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cell.2014.12.033","volume":"160","author":"MS Rooney","year":"2015","unstructured":"Rooney, M. S., Shukla, S. A., Wu, C. J., Getz, G. & Hacohen, N. Molecular and genetic properties of tumors associated with local immune cytolytic activity. Cell 160, 48\u201361 (2015).","journal-title":"Cell"},{"key":"1775_CR40","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/ni1102-991","volume":"3","author":"GP Dunn","year":"2002","unstructured":"Dunn, G. P., Bruce, A. T., Ikeda, H., Old, L. J. & Schreiber, R. D. Cancer immunoediting: from immunosurveillance to tumor escape. Nat. Immunol. 3, 991\u2013998 (2002).","journal-title":"Nat. Immunol."},{"key":"1775_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-016-0264-5","volume":"8","author":"J Hundal","year":"2016","unstructured":"Hundal, J. et al. pVAC-Seq: A genome-guided in silico approach to identifying tumor neoantigens. Genome Med. 8, 11 (2016).","journal-title":"Genome Med."},{"key":"1775_CR42","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman, A. M. et al. Robust enumeration of cell subsets from tissue expression profiles. Nat. Methods 12, 453\u2013457 (2015).","journal-title":"Nat. Methods"},{"key":"1775_CR43","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/s41586-019-1032-7","volume":"567","author":"R Rosenthal","year":"2019","unstructured":"Rosenthal, R. et al. Neoantigen-directed immune escape in lung cancer evolution. Nature 567, 479\u2013485 (2019).","journal-title":"Nature"},{"key":"1775_CR44","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1124\/dmd.114.062745","volume":"43","author":"TJ Raub","year":"2015","unstructured":"Raub, T. J. et al. Brain exposure of two selective dual CDK4 and CDK6 inhibitors and the antitumor activity of CDK4 and CDK6 inhibition in combination with temozolomide in an intracranial glioblastoma xenograft. Drug Metab. Dispos. 43, 1360\u20131371 (2015).","journal-title":"Drug Metab. Dispos."},{"key":"1775_CR45","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1007\/s00280-017-3451-1","volume":"80","author":"M van den Bent","year":"2017","unstructured":"van den Bent, M. et al. Efficacy of depatuxizumab mafodotin (ABT-414) monotherapy in patients with EGFR-amplified, recurrent glioblastoma: results from a multi-center, international study. Cancer Chemother. Pharmacol. 80, 1209\u20131217 (2017).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"1775_CR46","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/s41586-018-0792-9","volume":"565","author":"DB Keskin","year":"2019","unstructured":"Keskin, D. B. et al. Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial. Nature 565, 234\u2013239 (2019).","journal-title":"Nature"},{"key":"1775_CR47","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/nature13387","volume":"512","author":"T Schumacher","year":"2014","unstructured":"Schumacher, T. et al. A vaccine targeting mutant IDH1 induces antitumour immunity. Nature 512, 324\u2013327 (2014).","journal-title":"Nature"},{"key":"1775_CR48","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.cell.2013.09.034","volume":"155","author":"CW Brennan","year":"2013","unstructured":"Brennan, C. W. et al. The somatic genomic landscape of glioblastoma. Cell 155, 462\u2013477 (2013).","journal-title":"Cell"},{"key":"1775_CR49","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1002\/ijc.31184","volume":"142","author":"A Droop","year":"2018","unstructured":"Droop, A. et al. How to analyse the spatiotemporal tumour samples needed to investigate cancer evolution: a case study using paired primary and recurrent glioblastoma. Int. J. Cancer 142, 1620\u20131626 (2018).","journal-title":"Int. J. Cancer"},{"key":"1775_CR50","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.ccell.2015.07.012","volume":"28","author":"T Mazor","year":"2015","unstructured":"Mazor, T. et al. DNA methylation and somatic mutations converge on the cell cycle and define similar evolutionary histories in brain tumors. Cancer Cell 28, 307\u2013317 (2015).","journal-title":"Cancer Cell"},{"key":"1775_CR51","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.ccell.2015.07.013","volume":"28","author":"J Kim","year":"2015","unstructured":"Kim, J. et al. Spatiotemporal evolution of the primary glioblastoma genome. Cancer Cell 28, 318\u2013328 (2015)","journal-title":"Cancer Cell"},{"key":"1775_CR52","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/ng.3273","volume":"47","author":"H Suzuki","year":"2015","unstructured":"Suzuki, H. et al. Mutational landscape and clonal architecture in grade II and III gliomas. Nat. Genet. 47, 458\u2013468 (2015).","journal-title":"Nat. Genet."},{"key":"1775_CR53","doi-asserted-by":"publisher","first-page":"3600","DOI":"10.1093\/bioinformatics\/bty350","volume":"34","author":"J K\u00f6ster","year":"2018","unstructured":"K\u00f6ster, J. & Rahmann, S. Snakemake\u2014a scalable bioinformatics workflow engine. Bioinformatics 34, 3600 (2018).","journal-title":"Bioinformatics"},{"key":"1775_CR54","doi-asserted-by":"publisher","first-page":"11.10.11","DOI":"10.1002\/0471250953.bi1110s43","volume":"43","author":"GA Van der Auwera","year":"2013","unstructured":"Van der Auwera, G. A. et al. From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline. Curr. Protoc. Bioinformatics. 43, 11.10.11\u201311.10.33 (2013).","journal-title":"Curr. Protoc. Bioinformatics."},{"key":"1775_CR55","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1093\/bioinformatics\/btw354","volume":"32","author":"P Ewels","year":"2016","unstructured":"Ewels, P., Magnusson, M., Lundin, S. & K\u00e4ller, M. MultiQC: summarize analysis results for multiple tools and samples in a single report. Bioinformatics 32, 3047\u20133048 (2016).","journal-title":"Bioinformatics"},{"key":"1775_CR56","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. et al. The Sequence Alignment\/Map format and SAMtools. Bioinformatics 25, 2078\u20132079 (2009).","journal-title":"Bioinformatics"},{"key":"1775_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2011-12-4-r41","volume":"12","author":"CH Mermel","year":"2011","unstructured":"Mermel, C. H. et al. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 12, R41 (2011).","journal-title":"Genome Biol."},{"key":"1775_CR58","doi-asserted-by":"publisher","first-page":"20007","DOI":"10.1073\/pnas.0710052104","volume":"104","author":"R Beroukhim","year":"2007","unstructured":"Beroukhim, R. et al. Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. Proc. Natl Acad. Sci. USA 104, 20007\u201320012 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1775_CR59","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.ccell.2018.03.007","volume":"33","author":"AM Taylor","year":"2018","unstructured":"Taylor, A. M. et al. Genomic and functional approaches to understanding cancer aneuploidy. Cancer Cell 33, 676\u2013689.e673 (2018).","journal-title":"Cancer Cell"},{"key":"1775_CR60","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/nmeth.2883","volume":"11","author":"A Roth","year":"2014","unstructured":"Roth, A. et al. PyClone: statistical inference of clonal population structure in cancer. Nat. Methods 11, 396\u2013398 (2014).","journal-title":"Nat. Methods"},{"key":"1775_CR61","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.cell.2018.03.057","volume":"173","author":"S Turajlic","year":"2018","unstructured":"Turajlic, S. et al. Tracking cancer evolution reveals constrained routes to metastases: TRACERx Renal. Cell 173, 581\u2013594.e512 (2018).","journal-title":"Cell"},{"key":"1775_CR62","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1101\/gr.180281.114","volume":"24","author":"G Ha","year":"2014","unstructured":"Ha, G. et al. TITAN: inference of copy number architectures in clonal cell populations from tumor whole-genome sequence data. Genome Res. 24, 1881\u20131893 (2014).","journal-title":"Genome Res."},{"key":"1775_CR63","doi-asserted-by":"publisher","first-page":"3310","DOI":"10.1093\/bioinformatics\/btu548","volume":"30","author":"A Szolek","year":"2014","unstructured":"Szolek, A. et al. OptiType: precision HLA typing from next-generation sequencing data. Bioinformatics 30, 3310\u20133316 (2014).","journal-title":"Bioinformatics"},{"key":"1775_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00251-008-0341-z","volume":"61","author":"I Hoof","year":"2009","unstructured":"Hoof, I. et al. NetMHCpan, a method for MHC class I binding prediction beyond humans. Immunogenetics 61, 1\u201313 (2009).","journal-title":"Immunogenetics"}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-019-1775-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-019-1775-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-019-1775-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T09:25:12Z","timestamp":1650619512000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-019-1775-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,20]]},"references-count":64,"journal-issue":{"issue":"7785","published-print":{"date-parts":[[2019,12,5]]}},"alternative-id":["1775"],"URL":"https:\/\/doi.org\/10.1038\/s41586-019-1775-1","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.736936195.793569387","asserted-by":"object"}]},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,20]]},"assertion":[{"value":"8 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.G.W.V. declares equity in Boundless Bio, Inc. M.K. receives research grants from BMS and ABBVie. P.K.B. is a consultant for Lilly, Genentech-Roche, Angiochem and Tesaro. P.K.B. receives institutional funding from Merck and Pfizer and honoraria from Merch and Genentech-Roche. W.K.A.Y. serves in a consulting or advisory role at DNAtrix Therapeutics. M.W. receives funding from Acceleron, Actelion, Bayer, Isarna, Merck, Sharp & Dohme, Merck (EMD, Darmstadt), Novocure, OGD2, Pigur and Roche as well as honoraria from BMS, Celldex, Immunocellular Therapeutics, Isarna, Magforce, Merck, Sharp & Dohme, Merck (EMD, Darmstadt), Northwest Biotherapeutics, Novocure, Pfizer, Roche, Teva and Tocagen. G. Reifenberger receives funding from Roche and Merck (EMD, Darmstadt) as well as honoraria from AbbVie. M. Smits is a central reviewer for Parexel Ltd and honoraria are paid to the institution. G. Tabatabai reports personal fees from Bristol-Myers-Squibb, personal fees from AbbVie, personal fees from Novocure, personal fees from Medac, travel grants from Bristol-Myers-Squibb, education grants from Novocure, research grants from Roche Diagnostics, research grants from Medac, membership in the National Steering board of the TIGER NIS (Novocure) and the International Steering board of the ON-TRK NIS (Bayer).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}